Related Experiment Videos
Point of care testing: improving pediatric outcomes
1Cardiac Intensive Care Program, Miami Children's Hospital, Miami, FL 33155, USA. anthony.rossi@mch.com
Clinical Biochemistry
|June 9, 2004
Summary
Goal-directed therapy combined with point-of-care testing significantly reduced mortality in pediatric congenital heart surgery patients. This approach showed the greatest benefit in the youngest and highest-risk surgical groups.
Area of Science:
- Pediatric Cardiac Surgery
- Critical Care Medicine
- Point-of-Care Testing
Background:
- Goal-directed therapy (GDT) is established for reducing critical illness mortality.
- Point-of-care testing (POCT) offers rapid results but lacks outcome data.
- Impact of GDT and POCT on congenital heart surgery outcomes is unevaluated.
Purpose of the Study:
- To evaluate the combined impact of GDT and POCT on mortality in pediatric congenital heart surgery patients.
- To assess if this combined strategy improves outcomes in high-risk and young patient populations.
Main Methods:
- Prospective incorporation of i-STAT POCT for lactate monitoring post-congenital heart surgery (July 2001).
- Serial lactate measurements guided therapy adjustments over 24 hours.
- Comparison of 30-day mortality between GDT+POCT group (n=378) and historical controls (n=851) using RACHS-1 risk scoring.
Main Results:
- Overall 30-day mortality decreased significantly in the GDT+POCT group (2.4% vs. 6.2%, P < 0.007).
- Neonatal mortality saw a significant reduction (4.3% vs. 12%, P = 0.008).
- Highest-risk surgeries (RACHS-1 groups 5+6) showed a 70% mortality reduction (9% vs. 30%, P = 0.03).
Conclusions:
- The combination of GDT and POCT significantly reduces mortality in pediatric congenital heart surgery.
- The benefits are most pronounced in neonates and patients undergoing high-risk procedures.
- This integrated approach represents a significant advancement in post-operative care for this population.